INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Transitioning From Using RUO To cGMP Chemicals For Clinical Trials

  Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.

• cGMP Assurance of Supply Services

  Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth.

• Over The Hurdles: Taking Psychedelics From Schedule I To Pharmacy

  Learn how a partner with experience in handling scheduled substances and navigating FDA and DEA regulation can help you advance toward clinical research and drug development with ease.

• Optimized Stability Storage

  A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.

• Key Takeaways Of Annex 1: What It Means For Your Cold Chain Management

  10/19/2023

  What are the practical implications of the latest Annex 1 update, specifically for cold chain management?

• Maximizing The Potential Of Cell Therapy Products

  6/3/2024

  Explore a variety of all-in-one, ready-to-use, chemically-defined, and animal-component-free cryopreservation solutions for overcoming the challenges of shipping cell therapy products.

• Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site

  6/11/2025

  Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

• Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

  1/22/2025

  Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.